• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“无加重时间”评估慢性阻塞性肺疾病(COPD)患者加重的影响:一项前瞻性观察研究。

'Exacerbation-free time' to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): a prospective observational study.

机构信息

Department of Primary and Community Care, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, The Netherlands.

Department of Pulmonary Diseases, Groningen Research Institute for Asthma and COPD, University Medical Center Groningen, Groningen, The Netherlands.

出版信息

NPJ Prim Care Respir Med. 2018 Apr 3;28(1):12. doi: 10.1038/s41533-018-0079-5.

DOI:10.1038/s41533-018-0079-5
PMID:29615628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5882661/
Abstract

COPD exacerbations are commonly quantified as rate per year. However, the total amount of time a patient suffers from exacerbations may be stronger related to his or her disease burden than just counting exacerbation episodes. In this study, we examined the relationship between exacerbation frequency and exacerbation-free time, and their associations with baseline characteristics and health-related quality of life. A total of 166 COPD patients reported symptom changes during 12 months. Symptom-defined exacerbation episodes were correlated to the number of exacerbation-free weeks per year. Analysis of covariance was used to examine the effects of baseline characteristics on annual exacerbation frequency and exacerbation-free weeks, Spearman's rank correlations to examine associations between the two methods to express exacerbations and the Chronic Respiratory Questionnaire (CRQ). The correlation between exacerbation frequency and exacerbation-free weeks was -0.71 (p < 0.001). However, among frequent exacerbators (i.e., ≥3 exacerbations/year, n = 113) the correlation was weak (r = -0.25; p < 0.01). Smokers had less exacerbation-free weeks than non-smokers (β = -5.709, p < 0.05). More exacerbation-free weeks were related to better CRQ Total (r = 0.22, p < 0.05), Mastery (r = 0.22, p < 0.05), and Fatigue (r = 0.23, p < 0.05) scores, whereas no significant associations were found between exacerbation frequency and CRQ scores. In COPD patients with frequent exacerbations, there is substantial variation in exacerbation-free time. Exacerbation-free time may better reflect the burden of exacerbations in patients with COPD than exacerbation frequency does.

摘要

COPD 加重通常以每年的发生率来定量。然而,患者患加重的总时间可能比仅仅计算加重发作次数更与他或她的疾病负担相关。在这项研究中,我们检查了加重发作频率与无加重发作时间之间的关系,以及它们与基线特征和健康相关生活质量之间的关系。共有 166 名 COPD 患者在 12 个月内报告了症状变化。症状定义的加重发作与每年无加重发作的周数相关。协方差分析用于检查基线特征对每年加重发作频率和无加重发作周数的影响,Spearman 秩相关用于检查两种表达加重方法之间的关系以及慢性呼吸问卷(CRQ)。加重发作频率与无加重发作周数之间的相关性为-0.71(p<0.001)。然而,在频繁加重者(即≥3 次/年,n=113)中,相关性较弱(r=-0.25;p<0.01)。吸烟者的无加重发作周数少于非吸烟者(β=-5.709,p<0.05)。更多的无加重发作周数与更好的 CRQ 总评分(r=0.22,p<0.05)、掌握评分(r=0.22,p<0.05)和疲劳评分(r=0.23,p<0.05)相关,而加重发作频率与 CRQ 评分之间没有显著相关性。在频繁加重的 COPD 患者中,无加重发作时间存在很大差异。无加重发作时间可能比加重发作频率更能反映 COPD 患者的加重负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ce1/5882661/05a2a8011ac6/41533_2018_79_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ce1/5882661/a23f5c36abd3/41533_2018_79_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ce1/5882661/05a2a8011ac6/41533_2018_79_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ce1/5882661/a23f5c36abd3/41533_2018_79_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ce1/5882661/05a2a8011ac6/41533_2018_79_Fig2_HTML.jpg

相似文献

1
'Exacerbation-free time' to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): a prospective observational study.“无加重时间”评估慢性阻塞性肺疾病(COPD)患者加重的影响:一项前瞻性观察研究。
NPJ Prim Care Respir Med. 2018 Apr 3;28(1):12. doi: 10.1038/s41533-018-0079-5.
2
Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?频繁的中度加重是否会导致戒烟者慢性阻塞性肺疾病的进展?
Int J Chron Obstruct Pulmon Dis. 2015 Mar 10;10:525-33. doi: 10.2147/COPD.S76475. eCollection 2015.
3
Impact of mild exacerbation on COPD symptoms in a Japanese cohort.轻度加重对日本队列中慢性阻塞性肺疾病(COPD)症状的影响。
Int J Chron Obstruct Pulmon Dis. 2016 Jun 9;11:1269-78. doi: 10.2147/COPD.S105454. eCollection 2016.
4
Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病中延长的急性加重期恢复的影响
Am J Respir Crit Care Med. 2015 Oct 15;192(8):943-50. doi: 10.1164/rccm.201412-2269OC.
5
The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.慢性阻塞性肺疾病评估测试提高了既往加重对慢性阻塞性肺疾病不良结局的预测价值。
Int J Chron Obstruct Pulmon Dis. 2015 Nov 30;10:2571-9. doi: 10.2147/COPD.S91163. eCollection 2015.
6
Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations.慢性阻塞性肺疾病评估测试在评估 COPD 加重严重程度中的作用。
Am J Respir Crit Care Med. 2012 Jun 1;185(11):1218-24. doi: 10.1164/rccm.201110-1843OC. Epub 2012 Jan 26.
7
"Frequent exacerbator" is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease.“频繁急性加重者”是日本慢性阻塞性肺疾病患者中预后较差的一种表型。
Int J Chron Obstruct Pulmon Dis. 2016 Feb 3;11:207-16. doi: 10.2147/COPD.S98205. eCollection 2016.
8
The CAT (COPD Assessment Test) questionnaire as a predictor of the evolution of severe COPD exacerbations.慢性阻塞性肺疾病评估测试(CAT)问卷作为严重慢性阻塞性肺疾病急性加重演变的预测指标。
Respir Med. 2015 Dec;109(12):1546-52. doi: 10.1016/j.rmed.2015.10.011. Epub 2015 Oct 27.
9
COPD Assessment Test Changes from Baseline Correlate with COPD Exacerbations: A Longitudinal Analysis of the DACCORD Observational Study.COPD 评估测试从基线开始的变化与 COPD 加重相关:DACCORD 观察性研究的纵向分析。
Lung. 2020 Jun;198(3):507-514. doi: 10.1007/s00408-020-00357-y. Epub 2020 May 4.
10
Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.患有和未患有慢性阻塞性肺疾病的吸烟者的急性加重期及肺功能丧失
Am J Respir Crit Care Med. 2017 Feb 1;195(3):324-330. doi: 10.1164/rccm.201605-1014OC.

引用本文的文献

1
Characteristics and actions in high-risk COPD in unstable patients: The EPOCONSUL audit.不稳定患者中高危慢性阻塞性肺疾病(COPD)的特征与行为:EPOCONSUL审计
PLoS One. 2025 Jul 18;20(7):e0327775. doi: 10.1371/journal.pone.0327775. eCollection 2025.
2
Prevalence and clinical characterisation of thyroid dysfunction in COPD: a systematic review and meta-analysis.慢性阻塞性肺疾病中甲状腺功能障碍的患病率及临床特征:一项系统评价和荟萃分析。
Front Med (Lausanne). 2025 Apr 30;12:1571165. doi: 10.3389/fmed.2025.1571165. eCollection 2025.
3
Red cell distribution width related to the severity of the disease in patients with AECOPD.

本文引用的文献

1
Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients.医院招募患者和社区招募患者中使用情况及症状定义的慢性阻塞性肺疾病加重的发生率。
Int J Chron Obstruct Pulmon Dis. 2016 Sep 2;11:2099-108. doi: 10.2147/COPD.S108720. eCollection 2016.
2
Do self-management interventions in COPD patients work and which patients benefit most? An individual patient data meta-analysis.慢性阻塞性肺疾病(COPD)患者的自我管理干预措施是否有效,哪些患者受益最大?一项个体患者数据荟萃分析。
Int J Chron Obstruct Pulmon Dis. 2016 Aug 31;11:2063-74. doi: 10.2147/COPD.S107884. eCollection 2016.
3
红细胞分布宽度与慢性阻塞性肺疾病急性加重期患者疾病严重程度相关。
Biomark Med. 2025 Mar;19(5):177-186. doi: 10.1080/17520363.2025.2468152. Epub 2025 Mar 12.
4
Association of low attenuation area scores with pulmonary function and clinical prognosis in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者低衰减区评分与肺功能及临床预后的相关性
Open Life Sci. 2024 Aug 14;19(1):20220871. doi: 10.1515/biol-2022-0871. eCollection 2024.
5
Effects of Adherence to an mHealth Tool for Self-Management of COPD Exacerbations.使用移动医疗工具改善 COPD 加重期自我管理的效果。
Int J Chron Obstruct Pulmon Dis. 2023 Nov 1;18:2381-2389. doi: 10.2147/COPD.S431199. eCollection 2023.
6
Giving Voice to People - Experiences During Mild to Moderate Acute Exacerbations of COPD.倾听患者心声——慢性阻塞性肺疾病轻度至中度急性加重期的经历
Chronic Obstr Pulm Dis. 2022 Jul 29;9(3):336-348. doi: 10.15326/jcopdf.2022.0283.
7
The prevalence and related factors of fatigue in patients with COPD: a systematic review.慢性阻塞性肺疾病患者疲劳的患病率及相关因素:系统评价。
Eur Respir Rev. 2021 Apr 13;30(160). doi: 10.1183/16000617.0298-2020. Print 2021 Jun 30.
8
Assessing the Usefulness of the Prevexair Smartphone Application in the Follow-Up High-Risk Patients with COPD.评估 Prevexair 智能手机应用在 COPD 高危患者随访中的实用性。
Int J Chron Obstruct Pulmon Dis. 2021 Jan 8;16:53-65. doi: 10.2147/COPD.S279394. eCollection 2021.
9
Compliance and Utility of a Smartphone App for the Detection of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease: Cohort Study.用于检测慢性阻塞性肺疾病患者加重情况的智能手机应用程序的依从性和实用性:队列研究。
JMIR Mhealth Uhealth. 2020 Mar 19;8(3):e15699. doi: 10.2196/15699.
10
Healthcare Professionals' Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease.医疗保健专业人员在慢性阻塞性肺疾病新药评估中首选的疗效终点和最小临床重要差异
Front Pharmacol. 2020 Feb 6;10:1519. doi: 10.3389/fphar.2019.01519. eCollection 2019.
Continuing to Confront COPD International Patient Survey: Economic Impact of COPD in 12 Countries.
持续直面慢性阻塞性肺疾病国际患者调查:12个国家慢性阻塞性肺疾病的经济影响
PLoS One. 2016 Apr 19;11(4):e0152618. doi: 10.1371/journal.pone.0152618. eCollection 2016.
4
Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病中延长的急性加重期恢复的影响
Am J Respir Crit Care Med. 2015 Oct 15;192(8):943-50. doi: 10.1164/rccm.201412-2269OC.
5
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease.美国胸科学会/欧洲呼吸学会官方声明:慢性阻塞性肺疾病研究问题。
Am J Respir Crit Care Med. 2015 Apr 1;191(7):e4-e27. doi: 10.1164/rccm.201501-0044ST.
6
Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.慢性阻塞性肺疾病急性加重的预防:美国胸科医师学会和加拿大胸科学会指南
Chest. 2015 Apr;147(4):894-942. doi: 10.1378/chest.14-1676.
7
Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial.在 POET-COPD 试验中对加重风险和加重表型的特征描述。
Respir Res. 2013 Oct 29;14(1):116. doi: 10.1186/1465-9921-14-116.
8
Comprehensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: randomised controlled trial.全科医学中慢性阻塞性肺疾病患者的综合自我管理和常规监测:随机对照试验。
BMJ. 2012 Nov 28;345:e7642. doi: 10.1136/bmj.e7642.
9
Exacerbation frequency and course of COPD.COPD 的加重频率和过程。
Int J Chron Obstruct Pulmon Dis. 2012;7:653-61. doi: 10.2147/COPD.S34186. Epub 2012 Sep 21.
10
Decline of health status sub-domains by exacerbations of chronic obstructive pulmonary disease: a prospective survey.慢性阻塞性肺疾病恶化导致健康状况亚领域下降:一项前瞻性调查。
Respiration. 2013;85(3):236-43. doi: 10.1159/000339925. Epub 2012 Aug 22.